For evaluating the impact strength of dental materials, the Izod test or Charpy test has been used, but specimen preparation for these tests is difficult due to the adjustment of a notch on them. By contrast, a weight-drop impact test does not require notched specimens. Therefore, it might be possible to measure the impact strength more accurately than conventional methods. This study aimed to establish appropriate conditions for applying the weight-drop impact test on small specimens of acrylic resin. To determine the most reliable impact fracture energy of acrylic resins, different diameters and thicknesses of PMMA resin specimens, diameters and weights of the striker, and diameters of the supporting jig were compared. For all specimen thicknesses, when the striker diameter was 6-10 mm, the impact fracture energy was constant when the inner diameter of the specimen-supporting jig was 8-10 mm. In addition, the measured E value was mostly equal to the median value of the impact fracture energy. Thus, for the weight-drop impact test, this method was effective for material testing of small specimens, by clearly specifying the test conditions, such as the thickness of disc-shaped specimens, the diameter of the striker, and the inner diameter of the specimen-supporting jig.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760405 | PMC |
http://dx.doi.org/10.3390/polym12122803 | DOI Listing |
Transl Psychiatry
January 2025
Laboratory of Exercise and Neurobiology, School of Physical Education and Sports Science, South China Normal University, Guangzhou, 510006, Guangdong, China.
Repeated closed-head injuries (rCHI) from activities like contact sports, falls, military combat, and traffic accidents pose a serious risk due to their cumulative impact on the brain. Often, rCHI is not diagnosed until symptoms of irreversible brain damage appear, highlighting the need for preventive measures. This study assessed the prophylactic efficacy of remote photobiomodulation (PBM) targeted at the lungs against rCHI-induced brain injury and associated behavioral deficits.
View Article and Find Full Text PDFBrain Res
December 2024
Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Chronic traumatic encephalopathy (CTE) has attracted attention due to sports-related head trauma or repetitive mild traumatic brain injury (mTBI). However, the pathology of CTE remains underexplored. Reproducible and quantitative model of CTE has yet to be established.
View Article and Find Full Text PDFNeurocrit Care
December 2024
Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark.
Front Immunol
December 2024
Department of Neurology, Ulm University, Ulm, Germany.
Background: Traumatic brain injury (TBI) induces an acute reactive state of microglia, which contribute to secondary injury processes through phagocytic activity and release of cytokines. Several receptor tyrosine kinases (RTK) are activated in microglia upon TBI, and their blockade may reduce the acute inflammation and decrease the secondary loss of neurons; thus, RTKs are potential therapeutic targets. We have previously demonstrated that several members of the Fibroblast Growth Factor Receptor (FGFR) family are transiently phosporylated upon TBI; the availability for drug repurposing of FGFR inhibitors makes worthwhile the elucidation of the role of FGFR in the acute phases of the response to TBI and the effect of FGFR inhibition.
View Article and Find Full Text PDFAdv Neurobiol
October 2024
Departments of Physical Medicine & Rehabilitation, Critical Care Medicine, and Psychology, and Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine, John G. Rangos Research Center, Pittsburgh, PA, USA.
Pediatric traumatic brain injury (TBI) is a significant healthcare issue, but potential treatments are absent despite robust investigation in several clinical trials. Factors attributed to clinical TBI, such as heterogeneity of injury and single-dose pharmacological treatments as well as timing of administration, may be reasons for the negative studies. Preclinical models of TBI can reduce some of the impediments by highlighting differences in injury depending on injury severity and location and by conducting dose response studies, thus providing better therapeutic targets and pharmacological profiles for clinical use.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!